Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Chagas disease is caused by Trypanosoma cruzi. The persistence of the parasite is associated with the disease chronicity and the impairment of the cellular immune response. It has been reported that the CD4+CD8+ T cell population expands in chronic Chagas disease patients. Few studies have focused o...
Saved in:
Main Authors: | Elena Pérez-Antón (Author), Adriana Egui (Author), M Carmen Thomas (Author), Concepción J Puerta (Author), John Mario González (Author), Adriana Cuéllar (Author), Manuel Segovia (Author), Manuel Carlos López (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.
by: Elena Pérez-Antón, et al.
Published: (2021) -
CD8low T cells expanded following acute Trypanosoma cruzi infection and benznidazole treatment are a relevant subset of IFN-γ producers.
by: Alessandro Marins-, et al.
Published: (2020) -
Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.
by: Claudia Magalhães Calvet, et al.
Published: (2020) -
Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display.
by: Luis Antonio Rodriguez Carnero, et al.
Published: (2023) -
Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics.
by: Andrea Trochine, et al.
Published: (2014)